首页> 外文期刊>Expert opinion on biological therapy >Cancer testis antigens--their importance in immunotherapy and in the early detection of cancer.
【24h】

Cancer testis antigens--their importance in immunotherapy and in the early detection of cancer.

机译:睾丸癌抗原-它们在免疫疗法和癌症早期检测中的重要性。

获取原文
获取原文并翻译 | 示例
           

摘要

The development of successful immunotherapeutic strategies requires the identification and characterisation of immunogenic cancer antigens that will be recognised by the host immune system, leading to tumour rejection. The concept of immunotherapy is based on the assumption that antigenic structures expressed in tumours can be used for therapeutic approaches employing the autologous immune system or by the application of immunotherapeutic reagents. Based on this concept, there is a great need to gain profound knowledge of the actual protein/antigen expression and its distribution pattern within normal tissues and cancerous tissues. Cancer testis (CT) antigens represent a unique class of tumour antigens, which are expressed in a variety of cancerous tissues and are silent in normal tissues, except for the testis. Owing to their restricted gene expression in the testis and various malignancies, CT antigens represent potential defined targets for antigen-based vaccination and antigen-directed immunotherapy to control cancer growth. Moreover, the analysis of humoral and cellular immune responses to CT antigens has proved useful for identifying novel cancer serum biomarkers with potential implications in early diagnosis of cancer.
机译:成功的免疫治疗策略的发展需要鉴定和表征将由宿主免疫系统识别的免疫原性癌症抗原,从而导致肿瘤排斥。免疫疗法的概念是基于这样的假设,即肿瘤中表达的抗原结构可用于采用自体免疫系统或通过应用免疫治疗剂的治疗方法。基于该概念,非常需要获得关于实际蛋白质/抗原表达及其在正常组织和癌组织中的分布模式的深刻知识。睾丸癌(CT)抗原代表一类独特的肿瘤抗原,它在多种癌组织中表达,而在正常组织中则除外,除了睾丸。由于其在睾丸和各种恶性肿瘤中的基因表达受限,CT抗原代表了基于抗原的疫苗接种和抗原定向免疫疗法以控制癌症生长的潜在明确靶标。此外,已证明对CT抗原的体液和细胞免疫反应的分析可用于鉴定对癌症的早期诊断具有潜在意义的新型癌症血清生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号